CosciaM.: Trattamento delle forme cistitiche. strumentali postoperatorie (Ricerca controllata). Minerva chir., 29; 146–150 (1974).
2.
DegenL.: Antimicrobial activity of 5-nitro-2-furaldehvde-N-methyl-N-piperazinoacethydrazone, a new hydrosoluble nitrofurane derivative. Chemotherapy.17; 175–181 (1972).
3.
DegenL.: Antimicrobial activity of a series of new 5-nitro-2-furaldehyde aminoacethydrazones. Chemotherapy.17; 130–140 (1972).
4.
FontaniF.: Determination of Nifurpipone in Urine. J. Pharm. Sci., 61; 1502–1503 (1972).
5.
LaudiM.: Il Nifurpipone nelle affezioni infiammatorie delle vie urinane. Minerva urol., 25; 149–157 (1973).
6.
MassaramE., NardiD., DegenL., SetnikarI.: Nifurpipone, a new nitrofuran with a large antimicrobial spectrum. Experientia (Basel).27; 1243–1244 (1971).
RottìhufriD., MaffeisV.: Sperimentazione clinica di un nuovo derivato nitrofuranico. Urologia, 39; 359 (1972).
9.
SeñikarL., DegenL., MassaramE., NardiD.: Nifurpipone, a new nitrofuran for urinary tract infections. Abstracts VII International Congress of Chemotherapy. Prague 1971. I A-12/15.
10.
SftnikarL.: Caratteristiche antibatteriche, farmacologiche, farmacocinetiche e tossicologiche del Rê 15/0122, un derivato nitrofuranico. Studi preclinici. Settembre 1967.